G R O U P   S T A T S

  • 17 members
  • 13 members have PhDs
  • Backgrounds include: Organic and Inorganic Chemistry, Chemical Engineering, Material Science, Bioengineering, and Chemical Biology

Our CMT Group has expertise in virtually all areas of chemistry, chemical engineering, and materials science. All group members have advanced degrees from top universities including MIT, Harvard, and Stanford.

Client testimonial:
"The quality of our science is very high, and our inventors are really smart. The Wolf team understands our science, and that is critical.”

Our clients include top academic & research institutions such as Harvard Medical School, MIT, and Dana Farber Cancer Institute as well as growing companies in medical devices (DEKA), industrial filtration (Hollingsworth & Vose), and solid state lighting (Luminus Devices), to name a few. They call on us to protect their most valuable cutting edge technologies, such as new battery chemistries that deliver higher power, processes for forming biodegradable compositions, and light emitting device designs that enhance light emission.

Client testimonial:
"Wolf Greenfield attorneys really are able to put themselves in our shoes and understand our business. In addition to the hands-on prosecution and portfolio, they also provide more strategic advice regarding positioning portfolios, dealing with partners, and helping us get to a dominant position in our field so that we would be a beneficial partner to another entity.”

The group provides a full range of IP services including: patent preparation and prosecution, opinions and studies related to infringement and patentability, licensing, IP due diligence, interferences, oppositions, litigation, trademarks, and strategic counseling. In order to provide our clients with support on IP issues internationally, we also maintain close working relationships with associates around the world.

Client testimonial:
"We are very happy with Wolf Greenfield. They do an outstanding job for us. They stand out because they are always proactively reaching out and thinking about us.”
  • We drafted and prosecuted a patent (US6884823) on behalf of our client Trexel, Inc., the exclusive provider of MuCell® microcellular foam technology, related to injection molding of polymeric material. The patent was asserted against Master Industries, Inc. in a case that settled favorably at an early stage.
  • On behalf of our client Luminus Devices, which develops and manufactures high-performance LEDs, we drafted and prosecuted a portfolio of patents in the display space that were sold to Rambus Incorporated.

Representative clients:

Recent Articles:

April 8, 2015
"Diagnostic patenting since Myriad: an update" by Patrick R. H. Waller and Daniel W. Young
Stakeholders shouldn’t conclude that nothing is patent eligible in the diagnostic space. Read more

March 2014
"
CRISPR/Cas-9: An Exciting Addition to Genomic Editing"
by Patricia Granahan and Chelsea A. Loughran
This article provides an in-depth review of (1) the science behind this new technology, (2) several of the research groups responsible for the promising applications for this technology, and (3) the related and evolving intellectual property (IP) landscape. Read more

February 2014
"
The New World of Diagnostic Testing Post-Myriad"
by Patrick R. H. Waller and Daniel W. Young
Claims to isolated DNA segments that exist in nature are not patent eligible, but claims to certain synthetic molecules relevant to genetic testing—as well as certain method-of-use patents—likely remain patent eligible. Read more

To view older publications, go to Publications


G R O U P   S T A T S

  • 17 members
  • 13 members have PhDs
  • Backgrounds include: Organic and Inorganic Chemistry, Chemical Engineering, Material Science, Bioengineering, and Chemical Biology

Our CMT Group has expertise in virtually all areas of chemistry, chemical engineering, and materials science. All group members have advanced degrees from top universities including MIT, Harvard, and Stanford.

Client testimonial:
"The quality of our science is very high, and our inventors are really smart. The Wolf team understands our science, and that is critical.”

Our clients include top academic & research institutions such as Harvard Medical School, MIT, and Dana Farber Cancer Institute as well as growing companies in medical devices (DEKA), industrial filtration (Hollingsworth & Vose), and solid state lighting (Luminus Devices), to name a few. They call on us to protect their most valuable cutting edge technologies, such as new battery chemistries that deliver higher power, processes for forming biodegradable compositions, and light emitting device designs that enhance light emission.

Client testimonial:
"Wolf Greenfield attorneys really are able to put themselves in our shoes and understand our business. In addition to the hands-on prosecution and portfolio, they also provide more strategic advice regarding positioning portfolios, dealing with partners, and helping us get to a dominant position in our field so that we would be a beneficial partner to another entity.”

The group provides a full range of IP services including: patent preparation and prosecution, opinions and studies related to infringement and patentability, licensing, IP due diligence, interferences, oppositions, litigation, trademarks, and strategic counseling. In order to provide our clients with support on IP issues internationally, we also maintain close working relationships with associates around the world.

Client testimonial:
"We are very happy with Wolf Greenfield. They do an outstanding job for us. They stand out because they are always proactively reaching out and thinking about us.”
  • We drafted and prosecuted a patent (US6884823) on behalf of our client Trexel, Inc., the exclusive provider of MuCell® microcellular foam technology, related to injection molding of polymeric material. The patent was asserted against Master Industries, Inc. in a case that settled favorably at an early stage.
  • On behalf of our client Luminus Devices, which develops and manufactures high-performance LEDs, we drafted and prosecuted a portfolio of patents in the display space that were sold to Rambus Incorporated.

Representative clients:

Recent Articles:

April 8, 2015
"Diagnostic patenting since Myriad: an update" by Patrick R. H. Waller and Daniel W. Young
Stakeholders shouldn’t conclude that nothing is patent eligible in the diagnostic space. Read more

March 2014
"
CRISPR/Cas-9: An Exciting Addition to Genomic Editing"
by Patricia Granahan and Chelsea A. Loughran
This article provides an in-depth review of (1) the science behind this new technology, (2) several of the research groups responsible for the promising applications for this technology, and (3) the related and evolving intellectual property (IP) landscape. Read more

February 2014
"
The New World of Diagnostic Testing Post-Myriad"
by Patrick R. H. Waller and Daniel W. Young
Claims to isolated DNA segments that exist in nature are not patent eligible, but claims to certain synthetic molecules relevant to genetic testing—as well as certain method-of-use patents—likely remain patent eligible. Read more

To view older publications, go to Publications